Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atagabalin Dose-ranging Trial in Primary Insomnia
NCT00551148Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Atagabalin in Insomnia (5 arms), sponsored by Pfizer. Primary endpoint: Wake After Sleep Onset. Started Oct 2007; status: completed.
02
Drugs
Atagabalin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00551148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00551148.